OriCell's GPC3 CAR-T Phase II hepatocellular carcinoma trial receives Chinese regulatory clearance

Bayer reports positive Phase III FIND-CKD results for Kerendia in non-diabetic chronic kidney disease

Owkin to build AI agents as part of K Pro collaboration with Sanofi

Gilead and Lakefront complete Ouro Medicines acquisition to expand autoimmune disease pipeline

Kexing Biopharm begins enrolment for Phase I trial of GB10 in China

Lupeng Pharmaceutical's rocbrutinib receives Chinese approval to treat R/R mantle cell lymphoma

Pharming secures FDA acceptance of Joenja filing for children with APDS

UCB and Biogen present Phase 3 data highlighting potential of dapirolizumab pegol in lupus treatment

Persist AI partners with Microsize and Micromacinazione to launch drug formulation platform

RedHill Biopharma advancing opaganib options for Ebola outbreak

Sun Pharma receives American Skin Association 2026 Corporate Leadership Award

ADC Therapeutics reports trial results for ZYNLONTA - rituximab combination in relapsed or refractory diffuse large B-Cell lymphoma

Arcus Biosciences enters clinical trial collaboration with Bristol Myers Squibb in kidney cancer programme

Evogene completes Phase 1 study of BMC128 in combination with Nivolumab

Cumberland Pharmaceuticals and Vanderbilt Health report data from Phase 2a trial of ifetroban to prevent cancer metastasis